Zambon S.p.a.

Zaambon S.p.a.

Lucia Pallecchi

Gian Maria Rossolini

Francesco Sergio

A synergistic pharmacological association of N-acetylcysteine (NAC) and colistin for use in the treatment of a bacterial infection caused by one or more pathogens selected fromandstrains, in particular a bacterial infection associated with a respiratory tract disease, such as a chronic respiratory tract disease comprising cystic fibrosis (CF), bronchiectasis non CF and chronic obstructive pulmonary disease COPD is described.

Association of N-acetylcysteine and colistin for use in bacterial infections

The present invention relates to N-acetylcysteine for the use in the treatment of bacterial infections caused by a pathogen selected fromcomplex (BCC) and() strains.

N-acetylcysteine for use as antibacterial agent

A synergistic pharmacological association of N-acetylcysteine (NAC) and colistin for use in the treatment of a bacterial infection caused by one or more pathogens selected fromandstrains, in particular a bacterial infection associated with a respiratory tract disease, such as a chronic respiratory tract disease comprising cystic fibrosis (CF), bronchiectasis non CF and chronic obstructive pulmonary disease (COPD) is described.

Growing community of inventors

Colle di Val d'Elsa, Italy

Lucia Pallecchi